First UK patients receive experimental mRNA therapy for cancer in global trial
The phase 1/2 Mobilize trial is evaluating the safety and efficacy of mRNA-4359
Read More
Tag: Imperial College Healthcare NHS Trust
MRC Laboratory of Medical Sciences worth £120m opens on ICL campus
The institute is one of two UK laboratories wholly funded by the MRC
Read More
Prostate cancer focal therapy could improve costs and patient outcomes
Every year, over 44,000 men are diagnosed with prostate cancer in England
Read More
- UKHSA and ICL confirm variant which plays key role in global surge of Strep A infections
- Study reveals heart failure device could monitor patients and prevent hospitalisation
- MIT’s new MRI brain light-detecting technique could support brain cell studies
- PharmaTimes MSEA and NIEA awards are open for entry
- BBSRC invests £48m in Babraham Institute to advance lifelong health research
